Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989130 · ClinicalTrials.gov registry record · NA
Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01989130 is a NA study that has completed, run by George Washington University. The registered enrollment target is 70 participants.
The verdict
NCT01989130, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
Interventions
- DEVICE Roche AMPLICOR CT/NG
- DEVICE Cepheid Xpert CT/NG Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01989130
The ClinicalTrials.gov registry entry for NCT01989130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Roche AMPLICOR CT/NG is the first listed.
NCT01989130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01989130 about?
NCT01989130 is a clinical study titled "Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED". The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
What is the current status of trial NCT01989130?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01989130?
The interventions under investigation include: Roche AMPLICOR CT/NG (DEVICE), Cepheid Xpert CT/NG Test (DEVICE).
Who is sponsoring clinical trial NCT01989130?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.